Stifel on Dianthus Therapeutics (DNTH): 'today's update represents a best-case outcome, in our view'

March 9, 2026 7:25 AM

Stifel on Dianthus Therapeutics (NASDAQ: DNTH): 'today's update represents a best-case outcome, in our view'.The analyst comments "For the stock ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found